CCR2 (Plozalizumab Biosimilar) anticorps (Biotin)

N° du produit ABIN7607789

L’anticorps Humanized Monoclonal anti-CCR2 (Plozalizumab Biosimilar) a été validé pour FACS. Il convient pour détecter CCR2 (Plozalizumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour CCR2 (Plozalizumab Biosimilar) anticorps (Biotin) (ABIN7607789)

Antigène: CCR2 (Plozalizumab Biosimilar)

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp CCR2 (Plozalizumab Biosimilar) est conjugé à/à la Biotin

Application: Flow Cytometry (FACS)

Détail du produit anti-CCR2 (Plozalizumab Biosimilar) anticorps (Biotin)

Fonction: Biotinylated Anti-CCR2(plozalizumab biosimilar) mAb

Isotype: IgG1

Information d'application

Indications d'application: Flow Cyt 1:100

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Détails sur CCR2 (Plozalizumab Biosimilar)

Antigène: CCR2 (Plozalizumab Biosimilar)

Autre désignation: plozalizumab Biosimilar

Classe de substances: Biosimilar

Sujet: Synonyms Target:CC-CKR-2,CCR2A,CCR2B,CD192,CKR2,CKR2A,CKR2B,CMKBR2,MCP-1-R
Synonyms Antibody:MLN-1202, MLN1202, anti-CCR2, hu1D9